CG Dimono PTx 3ml

CG Dimono PTx, developed by Caregen, is the world’s first BTX type C peptide. Leveraging Caregen’s advanced peptide technology and exclusive transdermal delivery system, PTx offers a groundbreaking alternative to traditional BTX type A treatments. Unlike conventional methods, PTx does not require injections and provides efficient, fast, and safe results. CG Dimono PTx contains hyaluronic acid and an advanced peptide complex that is designed to be injected into the mid-to-deep dermal layer at the site of cutaneous depressions. These components work together to provide a comprehensive dermal filler treatment, ensuring optimal results. The active components work to immediately smooth facial wrinkles and folds while acting as a skinbooster, helping the body to renew and regenerate from within.